Deutsche Bank
FSTX

Deutsche Bank’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Deutsche Bank’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14
Closed – – 4995
2019
Q4 		$0 Sell
14
-11
-44% -$140 ﹤0.01% 5192
2019
Q3 		$0 Sell
25
-11,000
-100% -$181K ﹤0.01% 5399
2019
Q2 		$161K Buy
11,025
+6,649
+152% +$178K ﹤0.01% 3949
2019
Q1 		$183K Sell
4,376
-158
-3% -$6.66K ﹤0.01% 4057
2018
Q4 		$187K Sell
4,534
-3,583
-44% -$161K ﹤0.01% 3909
2018
Q3 		$391K Buy
8,117
+2,791
+52% +$140K ﹤0.01% 3911
2018
Q2 		$252K Buy
5,326
+5,126
+2,563% +$284K ﹤0.01% 4182
2018
Q1 		$12K Sell
200
-1,675
-89% -$88.4K ﹤0.01% 5104
2017
Q4 		$100K Sell
1,875
-5,900
-76% -$351K ﹤0.01% 4255
2017
Q3 		$523K Buy
7,775
+2,416
+45% +$138K ﹤0.01% 3398
2017
Q2 		$290K Buy
5,359
+5,334
+21,336% +$247K ﹤0.01% 3734
2017
Q1 		$0 Buy
+25
New +$857 ﹤0.01% 5168

Other funds holding FSTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
ED
Exane Derivatives Paris, France $174M AUM 7.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Deutsche Bank's FSTX Position: Q1 2020 in Review

Deutsche Bank sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2020, closing a stake of 14 shares.

Deutsche Bank first reported a position in FSTX in Q1 2017 and held it in 12 quarters. The position peaked at $523K in Q3 2017. 28 funds tracked by Wall St. Rank hold FSTX as of Q1 2020.

  • Deutsche Bank reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Deutsche Bank sold 14 F-star Therapeutics, Inc. Common Stock shares in Q1 2020.
  • Deutsche Bank first reported a position in F-star Therapeutics, Inc. Common Stock in Q1 2017 and held it in 12 quarters.
  • Deutsche Bank's F-star Therapeutics, Inc. Common Stock position peaked at $523K in Q3 2017.
  • 28 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.